About
About Sutro
Partnerships
Corporate Presentation
Leadership
Leadership Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Technology
XpressCF® and XpressCF+™ Platforms
Antibody-Drug Conjugates and IADCs
Bispecific and Engineered Antibodies
cGMP Facility
Investors
Company Presentation
Stock
Financials
Governance
Contact IR
Email Alerts
Pipeline
News
News Releases
Clinical / Scientific Presentation and Publication Highlights
Events
Careers & Culture
Join Our Team
Internships
Sutroites
Contact Us
Changing the future of
Oncology.
Sutro’s CEO, Bill Newell was Live Today on TD Ameritrade, The Watch List
Nov 20, 2019
